A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children Age 2 Years Through 6 Years

Clinical trial NCT02269488 · COMPLETED

Trial details

NCT number: NCT02269488
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Healthy Japanese Children Age 2 Years Through 6 Years

Start date: 2014-11-01
Primary completion: 2015-02-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.